8-K - Transcode Therapeutics, Inc. (0001829635) (Filer)

2026-09-28 14:17:25.83032+02

Economic importance 82/100 Credibility 81/100

Event subtypematerial_event

Filing form8-K

IssuerTranscode Therapeutics, Inc. (Filer)

Visibilityprimary

What happened

Filed: 2026-09-11 AccNo: 0001104659-26-107115 Size: 279 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Affected entities

Andorra Uncertain Impact 72/100 · Confidence 71% Venezuela Uncertain Impact 72/100 · Confidence 71% Türkiye Uncertain Impact 72/100 · Confidence 71% The Democratic Republic of Congo Uncertain Impact 72/100 · Confidence 71%

Sources used

SEC EDGAR — Latest filings 2026-09-28 14:16:10+02 · 96/100

Open original source

SEC EDGAR — Latest filings 2026-09-11 23:00:52+02 · 96/100

Open original source